Pages that link to "Q34487744"
Jump to navigation
Jump to search
The following pages link to Inhibition and induction of human cytochrome P450 (CYP) enzymes (Q34487744):
Displaying 50 items.
- Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone (Q24313179) (← links)
- Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line (Q28371944) (← links)
- Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes (Q28579888) (← links)
- Characterization of xenobiotic-metabolizing cytochrome P450 (CYP) forms in ringed and grey seals from the Baltic Sea and reference sites (Q31884732) (← links)
- Use of in vitro drug metabolism data to evaluate metabolic drug-drug interactions in man: the need for quantitative databases (Q31900846) (← links)
- Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. (Q32081610) (← links)
- Cardiac safety of ophthalmic timolol (Q33167596) (← links)
- Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity (Q33596274) (← links)
- Clinically significant pharmacokinetic interactions between dietary caffeine and medications (Q33916981) (← links)
- Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective (Q33954264) (← links)
- Cytochrome P450 2E1: its clinical and toxicological role (Q33962207) (← links)
- Evaluation of metabolism-mediated herb-drug interactions (Q34238039) (← links)
- Biotransformation of xenobiotics by amine oxidases (Q34316455) (← links)
- Screening of drug candidates for their drug--drug interaction potential (Q34318051) (← links)
- Clinically significant interactions with drugs used in the treatment of tuberculosis (Q34558656) (← links)
- Human CYPs: in vivo and clinical aspects (Q34627903) (← links)
- Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation. (Q35027930) (← links)
- Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. (Q35049310) (← links)
- Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism (Q35085025) (← links)
- Interactions of herbs with cytochrome P450. (Q35085032) (← links)
- Drug-activated nuclear receptors CAR and PXR. (Q35160978) (← links)
- Factors affecting the clinical development of cytochrome p450 3A substrates (Q35196196) (← links)
- Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms (Q35566353) (← links)
- Watson and Crick 50 years on. From double helix to pharmacogenomics (Q35630029) (← links)
- Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans (Q35863379) (← links)
- Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice (Q36012329) (← links)
- Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation (Q36055339) (← links)
- Prediction of drug metabolism and interactions on the basis of in vitro investigations. (Q36055562) (← links)
- The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs (Q36178890) (← links)
- Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice (Q36471008) (← links)
- CYP induction-mediated drug interactions: in vitro assessment and clinical implications (Q36485692) (← links)
- Antidepressant-drug interactions are potentially but rarely clinically significant (Q36538987) (← links)
- Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies (Q36546250) (← links)
- In vitro and in vivo metabolic studies of phospho-aspirin (MDC-22) (Q36700587) (← links)
- Comparative in vitro metabolism of phospho-tyrosol-indomethacin by mice, rats and humans (Q36703818) (← links)
- Tobacco control for anesthesiologists (Q36801501) (← links)
- Studies in vitamin E: biochemistry and molecular biology of tocopherol quinones (Q36879894) (← links)
- Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety (Q36960535) (← links)
- In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations (Q36985051) (← links)
- Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk (Q37492574) (← links)
- Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation (Q37557621) (← links)
- Metabolism of Ophthalmic Timolol: New Aspects of an Old Drug (Q37850837) (← links)
- Cytochrome P450-activated prodrugs (Q38077550) (← links)
- Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates (Q38307447) (← links)
- The effect of thiacloprid formulation on DNA/chromosome damage and changes in GST activity in bovine peripheral lymphocytes (Q38413073) (← links)
- An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies (Q38598487) (← links)
- Recent updates in utilizing prodrugs in drug delivery (2013-2015). (Q38702949) (← links)
- No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine (Q39810172) (← links)
- Quantitative drug interactions prediction system (Q-DIPS): a dynamic computer-based method to assist in the choice of clinically relevant in vivo studies (Q40681049) (← links)
- Mutagenicity of bisphenol A and its suppression by interferon-alpha in human RSa cells (Q40807485) (← links)